Fiera Capital (Canada)
REGN icon

Fiera Capital (Canada)’s Regeneron Pharmaceuticals REGN Stock Holding History

Fiera Capital (Canada)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-649
Closed -$534K – 533
2023
Q3 		$534K Buy
649
+15
+2% +$11.8K ﹤0.01% 415
2023
Q2 		$456K Buy
+634
New +$489K ﹤0.01% 438
2023
Q1 		– Sell
-846
Closed -$610K – 523
2022
Q4 		$610K Sell
846
-1,392
-62% -$1.03M ﹤0.01% 407
2022
Q3 		$1.54M Sell
2,238
-2,008
-47% -$1.26M 0.01% 332
2022
Q2 		$2.51M Sell
4,246
-97
-2% -$63.1K 0.01% 269
2022
Q1 		$3.03M Sell
4,343
-267
-6% -$169K 0.01% 269
2021
Q4 		$2.91M Sell
4,610
-762
-14% -$469K 0.01% 271
2021
Q3 		$3.25M Buy
5,372
+149
+3% +$92.5K 0.01% 233
2021
Q2 		$2.92M Buy
5,223
+1,004
+24% +$509K 0.01% 248
2021
Q1 		$2M Buy
4,219
+260
+7% +$127K 0.01% 291
2020
Q4 		$1.91M Buy
3,959
+2,994
+310% +$1.62M 0.01% 371
2020
Q3 		$541K Sell
965
-95
-9% -$57.6K ﹤0.01% 469
2020
Q2 		$660K Buy
+1,060
New +$602K ﹤0.01% 449
2018
Q4 		– Sell
-4,089
Closed -$1.65M – 718
2018
Q3 		$1.65M Buy
4,089
+304
+8% +$116K 0.01% 443
2018
Q2 		$1.31M Sell
3,785
-239
-6% -$74.7K 0.01% 450
2018
Q1 		$1.39M Sell
4,024
-16
-0.4% -$5.57K 0.01% 429
2017
Q4 		$1.52M Sell
4,040
-238
-6% -$96.4K 0.01% 404
2017
Q3 		$1.91M Sell
4,278
-1,693
-28% -$806K 0.01% 382
2017
Q2 		$2.93M Sell
5,971
-1,826
-23% -$799K 0.01% 354
2017
Q1 		$3.02M Buy
7,797
+50
+0.6% +$18.5K 0.02% 354
2016
Q4 		$2.84M Sell
7,747
-2,137
-22% -$813K 0.02% 409
2016
Q3 		$3.97M Buy
9,884
+692
+8% +$278K 0.02% 349
2016
Q2 		$3.21M Buy
9,192
+8,592
+1,432% +$3.31M 0.02% 381
2016
Q1 		$216K Buy
+600
New +$247K ﹤0.01% 539
2014
Q2 		– Sell
-700
Closed -$210K – 532
2014
Q1 		$210K Buy
+700
New +$216K ﹤0.01% 467
2013
Q3 		– Sell
-1,000
Closed -$225K – 371
2013
Q2 		$225K Buy
+1,000
New +$233K ﹤0.01% 343

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fiera Capital (Canada)'s REGN Position: Q4 2023 in Review

Fiera Capital (Canada) sold out of Regeneron Pharmaceuticals (REGN) in Q4 2023, closing a stake of 649 shares — an estimated $534K sold.

Fiera Capital (Canada) first reported a position in REGN in Q2 2013 and held it in 26 quarters. The position peaked at $3.97M in Q3 2016. 1,273 funds tracked by Wall St. Rank hold REGN as of Q4 2023.

  • Fiera Capital (Canada) reported no remaining Regeneron Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Fiera Capital (Canada) sold 649 Regeneron Pharmaceuticals shares in Q4 2023, an estimated $534K.
  • Fiera Capital (Canada) first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 26 quarters.
  • Fiera Capital (Canada)'s Regeneron Pharmaceuticals position peaked at $3.97M in Q3 2016.
  • 1,273 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2023.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2023, filed 8 Feb 2024.